AFG
RMD icon

Atomi Financial Group’s ResMed RMD Stock Holding History

Atomi Financial Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Sell
1,118
-512
-31% -$106K 0.01% 1179
2026
Q1 		$366K Sell
1,630
-98
-6% -$24.4K 0.01% 847
2025
Q4 		$416K Sell
1,728
-101
-6% -$25.8K 0.01% 779
2025
Q3 		$501K Buy
1,829
+505
+38% +$138K 0.02% 650
2025
Q2 		$342K Buy
1,324
+61
+5% +$14.6K 0.01% 752
2025
Q1 		$283K Buy
1,263
+187
+17% +$43.7K 0.01% 801
2024
Q4 		$246K Buy
+1,076
New +$259K 0.01% 821

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Atomi Financial Group's RMD Position: Q2 2026 in Review

Atomi Financial Group reduced its ResMed (RMD) stake by 31% in Q2 2026, selling an estimated $106K and leaving 1,118 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #1179.

Atomi Financial Group first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $501K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Atomi Financial Group held 1,118 shares of ResMed worth $218K as of Q2 2026.
  • Atomi Financial Group sold 512 ResMed shares in Q2 2026, an estimated $106K.
  • ResMed made up 0.01% of Atomi Financial Group's portfolio in Q2 2026, its #1179 holding.
  • Atomi Financial Group first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • Atomi Financial Group's ResMed position peaked at $501K in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.